Vimarsana
Biggest News Aggregation in the World

Page 38 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Therapy Today - Breaking & Trending Today

Moderna And Merck Drugs Successfully Treat Melanoma. - Vimarsana News

Moderna And Merck Drugs Successfully Treat Melanoma.

(CTN News) - Moderna and Merck, two prominent pharmaceutical companies in the United States, have announced the results of a clinical..........

Latest biotech news: fundraises, deals, clinical trials - Vimarsana News

Latest biotech news: fundraises, deals, clinical trials

What's been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.

MAPS PBC Seeks Approval of MDMA-Assisted Therapy for PTSD - Vimarsana News

MAPS PBC Seeks Approval of MDMA-Assisted Therapy for PTSD

MAPS Public Benefit Corporation is seeking approval of its MDMA (midomafetamine capsules)-assisted therapy for posttraumatic stress disorder.

Source: empr.com
Travere Therapeutics Initiates Pivotal Phase 3 Clinical Trial of Pegtibatinase for the Treatment of Classical Homocystinuria (HCU) - Vimarsana News

Travere Therapeutics Initiates Pivotal Phase 3 Clinical Trial of Pegtibatinase for the Treatment of Classical Homocystinuria (HCU)

Potential for pegtibatinase to become first disease-modifying treatment for classical HCU; topline data expected in 2026SAN DIEGO, Dec. 14, 2023 -- Travere Therapeutics, Inc. today announced the...

The First Leap to Receive Approval for a Novel Approach to PTSD Treatment | Husch Blackwell LLP - Vimarsana News

The First Leap to Receive Approval for a Novel Approach to PTSD Treatment | Husch Blackwell LLP

On December 12, 2023, the Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (“MAPS PBC”) announced it has submitted a new drug application (“NDA”) to the...